115 related articles for article (PubMed ID: 10525817)
1. Dynamic enhancement of upper abdominal organs in normal volunteers with MRI and effects of contrast dose reduction.
Coche EE; Bret PM; Reinhold C
Abdom Imaging; 1999; 24(6):604-9. PubMed ID: 10525817
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
[TBL] [Abstract][Full Text] [Related]
3. Dynamic MR imaging of the abdomen with gadopentetate dimeglumine: normal enhancement patterns of the liver, spleen, stomach, and pancreas.
Hamed MM; Hamm B; Ibrahim ME; Taupitz M; Mahfouz AE
AJR Am J Roentgenol; 1992 Feb; 158(2):303-7. PubMed ID: 1729787
[TBL] [Abstract][Full Text] [Related]
4. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
[TBL] [Abstract][Full Text] [Related]
5. Intraindividual Crossover Comparison of Gadoxetic Acid Dose for Liver MRI in Normal Volunteers.
Motosugi U; Bannas P; Hernando D; Salmani Rahimi M; Holmes JH; Reeder SB
Magn Reson Med Sci; 2016; 15(1):60-72. PubMed ID: 26104082
[TBL] [Abstract][Full Text] [Related]
6. Pancreas and peripancreatic vessels: effect of imaging delay on gadolinium enhancement at dynamic gradient-recalled-echo MR imaging.
Kanematsu M; Shiratori Y; Hoshi H; Kondo H; Matsuo M; Moriwaki H
Radiology; 2000 Apr; 215(1):95-102. PubMed ID: 10751473
[TBL] [Abstract][Full Text] [Related]
7. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol.
Zizka J; Klzo L; Ferda J; Mrklovský M; Bukac J
Eur J Radiol; 2007 May; 62(2):186-91. PubMed ID: 17367974
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of optimal scan delay for gadoxetate disodium-enhanced hepatic arterial phase MRI using MR fluoroscopic triggering and slow injection technique.
Goshima S; Kanematsu M; Kondo H; Watanabe H; Kawada H; Moriyama N; Bae KT
AJR Am J Roentgenol; 2013 Sep; 201(3):578-82. PubMed ID: 23971449
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer.
Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW
Magn Reson Med; 1994 Nov; 32(5):622-8. PubMed ID: 7808263
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced hepatic MRI: comparison of half-dose and standard-dose gadolinium DTPA administration in lesion characterization with T1-weighted gradient echo sequences.
De Corato DR; Krinsky GA; Rofsky NM; Earls JP; Lebowitz J; Weinreb JC
Clin Imaging; 1999; 23(5):302-10. PubMed ID: 10665348
[TBL] [Abstract][Full Text] [Related]
14. Quantitative magnetic resonance imaging of the normal feline cranial abdomen.
Newell SM; Graham JP; Roberts GD; Ginn PE; Chewning CL; Harrison JM; Andrzejewski C
Vet Radiol Ultrasound; 2000; 41(1):27-34. PubMed ID: 10695876
[TBL] [Abstract][Full Text] [Related]
15. Multivariable analysis of clinical influence factors on liver enhancement of Gd-EOB-DTPA-enhanced 3T MRI.
Verloh N; Haimerl M; Zeman F; Teufel A; Lang S; Stroszczynski C; Fellner C; Wiggermann P
Rofo; 2015 Jan; 187(1):29-35. PubMed ID: 25531338
[TBL] [Abstract][Full Text] [Related]
16. Normal abdominal enhancement patterns with dynamic gadolinium-enhanced MR imaging.
Mirowitz SA; Gutierrez E; Lee JK; Brown JJ; Heiken JP
Radiology; 1991 Sep; 180(3):637-40. PubMed ID: 1871272
[TBL] [Abstract][Full Text] [Related]
17. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-enhanced T1-weighted renal and abdominal MR imaging: quantitative discrepancy between clinical and in vitro findings.
Katzberg RW; Ivanovic M; Buonocore MH; Pellot-Barakat C; Brock JM; Ryan JM; Whang K
Acad Radiol; 2002 Jun; 9(6):679-87. PubMed ID: 12061742
[TBL] [Abstract][Full Text] [Related]
19. Effect of the rate of gadolinium injection on magnetic resonance pulmonary perfusion imaging.
Matsuoka S; Uchiyama K; Shima H; Terakoshi H; Oishi S; Nojiri Y; Ogata H
J Magn Reson Imaging; 2002 Jan; 15(1):108-13. PubMed ID: 11793465
[TBL] [Abstract][Full Text] [Related]
20. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA.
Zech CJ; Vos B; Nordell A; Urich M; Blomqvist L; Breuer J; Reiser MF; Weinmann HJ
Invest Radiol; 2009 Jun; 44(6):305-10. PubMed ID: 19462484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
